News Search

Category: Corporate Alliances

Penn spinout Verismo Therapeutics Makes Agreement to Fund University Research of KIR-CAR platform of Car-T to Target Solid Tumors

Learn about Penn spinout Verismo Therapeutics' agreement to fund four years of university research of KIR-CAR platform of Car-T to target solid tumors.

Gnubiotics and Penn Explore CAR-T Therapy

This collaboration will take place through company-sponsored pre-clinical research studies in the laboratory of Avery Posey, PhD, an assistant professor at the Perelman School of Medicine.

Five Years of Data Show Long-term Promise for Penn and Novartis’ Car-T Pioneer Kymriah

Five years after Penn and Novartis made history with the FDA approval of Kymriah, a recent study shows the long-term impact of the medication on patient remission rates. 

The Center for Breakthrough Medicines and Penn partner in the manufacturing of gene therapies

Penn’s Innovation in Process Science combines with CBM manufacturing capability to develop large-scale gene therapy manufacturing capacity, testing, and analytics

Penn inventors named Heroes of the Year by Time Magazine

Drs. Katalin Kariko and Drew Weissman, inventors of the foundational RNA research that led to the COVID-19 vaccines, are two of researchers named by Time Magazine as their Heroes of the Year 2021.

Passage Bio further expands Gene Therapy research partnership with Penn

Passage Bio has exercised two additional options for potential new drug candidates under its research collaboration with Penn's gene therapy program.

Celebration of Innovation 2021 Recap and Recording

The event honors the patent recipients from the previous fiscal year, as well as, those partners, inventors, and startups that made exceptional achievements.

Jean Bennett, M.D., Ph.D., joins REGENXBIO Board of Directors

She will serve as a member of REGENXBIO's Nominating and Corporate Governance Committee. 

iECURE emerges with $50M to search for ‘holy grail’ and ‘untapped frontier’ of gene editing

The biotech will use the funds for a slate of gene insertion programs for liver disorders out of the lab of gene therapy pioneer Jim Wilson, M.D., Ph.D. at Penn.

Filter

Skip to content